Exponent, Inc. (EXPO)

Revenue by Geography

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Oct 3, 2025	Jan 3, 2025	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021	Jan 3, 2020	Dec 28, 2018	Dec 29, 2017	Dec 30, 2016	Jan 1, 2016	Jan 2, 2015	Jan 3, 2014	Dec 28, 2012
United States Revenue	-	493.07M	470.08M
United States Revenue Growth	-	4.89%	4.36%
Foreign Countries Revenue	-	65.45M	66.69M
Foreign Countries Revenue Growth	-	-1.86%	6.11%
Revenue (Total)	571.36M	558.51M	536.77M
Revenue (Total) Growth	2.30%	4.05%	4.57%

Revenue

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Oct 3, 2025	Jan 3, 2025	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021	Jan 3, 2020	Dec 28, 2018	Dec 29, 2017	Dec 30, 2016	Jan 1, 2016	Jan 2, 2015	Jan 3, 2014	Dec 28, 2012
Engineering and Other Scientific Revenue	481.48M	469.54M	446.89M
Engineering and Other Scientific Revenue Growth	2.54%	5.07%	4.46%
Environmental and Health Revenue	89.87M	88.97M	89.88M
Environmental and Health Revenue Growth	1.01%	-1.01%	5.12%
Revenue (Total)	571.36M	558.51M	536.77M
Revenue (Total) Growth	2.30%	4.05%	4.57%

EBIT

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Oct 3, 2025	Jan 3, 2025	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021	Jan 3, 2020	Dec 28, 2018	Dec 29, 2017	Dec 30, 2016	Jan 1, 2016	Jan 2, 2015	Jan 3, 2014	Dec 28, 2012
Engineering and Other Scientific Operating Income	166.08M	164.88M	153.92M
Engineering and Other Scientific Operating Income Growth	0.73%	7.12%	0.81%
Environmental and Health Operating Income	31.10M	30.00M	28.43M
Environmental and Health Operating Income Growth	3.68%	5.50%	3.99%
Corporate Operating Income	-79.28M	-75.32M	-71.03M
Operating Income (Total)	117.90M	119.56M	111.32M
Operating Income (Total) Growth	-1.39%	7.40%	-20.96%

Capital Expenditures

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Oct 3, 2025	Jan 3, 2025	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021	Jan 3, 2020	Dec 28, 2018	Dec 29, 2017	Dec 30, 2016	Jan 1, 2016	Jan 2, 2015	Jan 3, 2014	Dec 28, 2012
Engineering and Other Scientific Capital Expenditures	2.96M	3.26M	3.90M
Engineering and Other Scientific Capital Expenditures Growth	-9.12%	-16.38%	-16.43%
Environmental and Health Capital Expenditures	121.00K	77.00K	170.00K
Environmental and Health Capital Expenditures Growth	57.14%	-54.71%	-2.30%
Corporate Capital Expenditures	6.34M	4.04M	14.63M
Corporate Capital Expenditures Growth	56.69%	-72.36%	87.28%

Key Performance Indicators

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Oct 3, 2025	Jan 3, 2025	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021	Jan 3, 2020	Dec 28, 2018	Dec 29, 2017	Dec 30, 2016	Jan 1, 2016	Jan 2, 2015	Jan 3, 2014	Dec 28, 2012
Technical Full-Time Equivalent Employees	976.00	967.00	1.05K
Technical Full-Time Equivalent Employees Growth	0.93%	-7.73%	9.74%

Updated Nov 7, 2025. Data Source: Fiscal.ai.